aha_2025
Différences
Ci-dessous, les différences entre deux révisions de la page.
| Les deux révisions précédentesRévision précédente | |||
| aha_2025 [2025/11/09 19:38] – clementbecle | aha_2025 [2025/11/09 19:39] (Version actuelle) – clementbecle | ||
|---|---|---|---|
| Ligne 3: | Ligne 3: | ||
| * [[LBS.02|LBS.02 Dilemmas in antithrombotic therapy in AF care post procedures]] : Adapt-AF, Optima-AF, Closure-AF et Ocean trial. | * [[LBS.02|LBS.02 Dilemmas in antithrombotic therapy in AF care post procedures]] : Adapt-AF, Optima-AF, Closure-AF et Ocean trial. | ||
| * [[LBS.03|LBS.03 Cutting Edge Valve and Coronary Trials]] : Recovery, Ablation trial, Favor-IV QVAS et Top trial. | * [[LBS.03|LBS.03 Cutting Edge Valve and Coronary Trials]] : Recovery, Ablation trial, Favor-IV QVAS et Top trial. | ||
| - | * [[LBS.04|LBS.04 Cardiometabolic and Lifestyle Interventions for AF]] | + | * [[LBS.04|LBS.04 Cardiometabolic and Lifestyle Interventions for AF]] : Dare-AF, Meta-AF et DECAF. |
| * [[LBS.05|LBS.05 Practice Changing Trials in Blood Pressure Control ]] | * [[LBS.05|LBS.05 Practice Changing Trials in Blood Pressure Control ]] | ||
| * [[LBS.06|LBS.06 Approaches to Ischemic Heart Disease Before During and After Hospitalization]] | * [[LBS.06|LBS.06 Approaches to Ischemic Heart Disease Before During and After Hospitalization]] | ||
aha_2025.txt · Dernière modification : de clementbecle